Jump Financial LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 933 shares of the semiconductor company's stock, valued at approximately $453,000.
Other institutional investors have also made changes to their positions in the company. Norges Bank bought a new position in Synopsys during the 4th quarter valued at about $583,608,000. Raymond James Financial Inc. bought a new position in Synopsys during the 4th quarter valued at about $199,065,000. Proficio Capital Partners LLC lifted its holdings in Synopsys by 71,578.5% during the 4th quarter. Proficio Capital Partners LLC now owns 386,347 shares of the semiconductor company's stock valued at $187,517,000 after purchasing an additional 385,808 shares during the last quarter. Alecta Tjanstepension Omsesidigt bought a new position in Synopsys during the 4th quarter valued at about $104,741,000. Finally, American Century Companies Inc. lifted its holdings in Synopsys by 38.7% during the 4th quarter. American Century Companies Inc. now owns 571,474 shares of the semiconductor company's stock valued at $277,371,000 after purchasing an additional 159,344 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the stock. Needham & Company LLC reissued a "buy" rating and set a $650.00 price target on shares of Synopsys in a report on Thursday, February 27th. Piper Sandler cut their price target on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Wells Fargo & Company cut their price target on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. Stifel Nicolaus set a $550.00 target price on shares of Synopsys in a research note on Monday. Finally, Mizuho dropped their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $613.43.
View Our Latest Report on SNPS
Synopsys Trading Down 0.4 %
Shares of SNPS traded down $1.76 on Wednesday, reaching $459.01. 1,338,134 shares of the company's stock were exchanged, compared to its average volume of 1,093,475. The stock has a market capitalization of $70.97 billion, a P/E ratio of 31.61, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23. The business has a 50 day moving average price of $434.54 and a two-hundred day moving average price of $490.84. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80.
Insider Buying and Selling
In related news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares in the company, valued at approximately $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.